In Frimline v. K-SMATCO, Delhi HC granted interim relief over patent IN 382949, citing strong prima facie infringement of Frimline’s pharmaceutical formulation.
Read more about Frimline v. K-SMATCO: Delhi HC Rules Firmly in Pharmaceutical Patent Infringement CaseCategory: Patents
Patent Refusal Cannot Be a Single Line: Calcutta High Court Calls for Reasoned Orders
In the case of Stromag GmbH vs. Controller General of Patents, the Calcutta High Court ruled that patent refusal orders must contain detailed reasoning. A single-line dismissal, the court said, does not meet the legal standards of a quasi-judicial function and is unsustainable.
Read more about Patent Refusal Cannot Be a Single Line: Calcutta High Court Calls for Reasoned OrdersInfrared-Based Biomolecule Detection is Not excluded under Section 3(i) of the Patents Act: Delhi HC
In the case of EMD Millipore Corporation vs Assistant Controller of Patents and Designs, the Delhi High Court held that a non-invasive method for analysing biomolecules is not excluded from patentability under Section 3(i). The Court allowed the applicant to revert to earlier claims and upheld the right to amend claims in appeal.
Read more about Infrared-Based Biomolecule Detection is Not excluded under Section 3(i) of the Patents Act: Delhi HCSection 3(i) and Diagnostic Patents: Court Upholds Refusal of Prenatal Testing Method
Delhi HC rules Sequenom’s NIPT methods are excluded as “diagnostic” under Section 3(i) and hit by 3(b) for sex selection concerns, while keeping the door open for tools and products.
Read more about Section 3(i) and Diagnostic Patents: Court Upholds Refusal of Prenatal Testing MethodRoche’s Appeal Dismissed, Path Open for Affordable Risdiplam in India
The Delhi High Court dismissed Roche’s appeal against Natco Pharma, finding the Risdiplam patent prima facie obvious due to its similarity with prior genus patents, paving the way for affordable generic SMA treatment in India.
Read more about Roche’s Appeal Dismissed, Path Open for Affordable Risdiplam in IndiaCalcutta High Court Clarifies Scope of Section 3(h) in Patent Law: Base SE v. Controller of Patents
In Base SE v. Deputy Controller of Patents, the Calcutta High Court ruled that scientific and technical inventions addressing agricultural problems are not excluded under Section 3(h). It also clarified that partial grant of patent claims is not permitted under Indian patent law.
Read more about Calcutta High Court Clarifies Scope of Section 3(h) in Patent Law: Base SE v. Controller of PatentsSaint-Gobain Patent Rejection: Delhi HC Finds No Inventive Step in Glass Coating Claim
Delhi HC upholds Saint-Gobain patent rejection, ruling that the glass coating claim lacked inventive step and failed to show technical advancement.
Read more about Saint-Gobain Patent Rejection: Delhi HC Finds No Inventive Step in Glass Coating ClaimOld Wine in New Bottle: Distillery Waste Patent Denied
Delhi HC affirms rejection of a patent on ZLD process from distillery waste, citing lack of inventive step and application of Section 3(d) of the Patents Act.
Read more about Old Wine in New Bottle: Distillery Waste Patent DeniedCourt Remands Patent Rejection Over IV Catheter, Cites Flawed Obviousness Test
Delhi HC sets aside patent rejection for IV catheter, citing flawed inventive step analysis under Agriboard test and lack of reasoned decision.
Read more about Court Remands Patent Rejection Over IV Catheter, Cites Flawed Obviousness TestNo Territorial Jurisdiction, No Quia Timet Relief: Lessons from a Patent Case
In the case of Helsinn Healthcare SA vs AET Laboratories, the Delhi High Court declined to entertain a patent infringement action filed in anticipation of future infringement. The Court examined the territorial reach of Indian courts in web-based patent matters and reaffirmed the principles required to sustain quia timet actions.
Read more about No Territorial Jurisdiction, No Quia Timet Relief: Lessons from a Patent Case